Article
Do drug transporter (ABCB1) SNPs influence cyclosporine and tacrolimus dose requirements and renal allograft outcome in the posttransplantation period?
Journal of clinical pharmacology - 1 Apr 2011
Singh Ranjana, Srivastava Aneesh, Kapoor Rakesh, Mittal Rama Devi
Abstract excerpt
Polymorphisms in the drug transporter gene (ABCB1) may play a significant role in individualizing cyclosporine (CsA) and tacrolimus (Tac) dosage and subsequently the allograft outcome in renal transplant recipients. In total, 225 recipients on CsA and 75 on Tac-based immunosuppression regimen were recruited, and 6 common polymorphic sites in the ABCB1 gene were analyzed for association with dose-adjusted levels...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
